GeLongHui, August 28th - Guiyang Xintian Pharmaceutical (002873.SZ) released its 2024 interim report, with a total operating income of 0.442 billion yuan during the reporting period, a year-on-year decrease of 16.01%; the net income attributable to the shareholders of the listed company was 30.3395 million yuan, a year-on-year decrease of 34.51%; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 29.513 million yuan, a year-on-year decrease of 30.33%; and the basic earnings per share was 0.1312 yuan.
新天药业(002873.SZ)：上半年净利润3033.95万元，同比下降34.51%
Guiyang Xintian Pharmaceutical (002873.SZ): The net income in the first half of the year was 30.3395 million yuan, a year-on-year decrease of 34.51%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated